Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text (PDF, 682K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sutton, R. B. Articles by Brunger, A. T. Search for Related Content PubMed PubMed Citation Articles by Sutton, R. B. Articles by Brunger, A. T. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/1999//589 $5.00
The Journal of Cell Biology, Volume 147, Number 3, , 1999 589-598

Crystal Structure of the Cytosolic C2a-C2b Domains of Synaptotagmin III

R. Bryan Sutton^a,b, James A. Ernst^c, and Axel T. Brunger^a,b

^a The Howard Hughes Medical Institute, Yale University, New Haven, Connecticut 06520
^b Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520
^c Department of Chemistry, Yale University, New Haven, Connecticut 06520
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520.(203) 432-6946(203) 432-6143

brunger{at}laplace.csb.yale.edu

Synaptotagmins are synaptic vesicle-associated, phospholipid-binding proteins most commonly associated with Ca⁺²-dependent exocytotic and Ca⁺²- independent endocytotic events. Synaptotagmin III is a 63.2-kD member of the synaptotagmin homology group; one of its characteristic properties is the ability to bind divalent cations and accessory proteins promiscuously. In the cytosolic portion of this protein, a flexible seven–amino acid linker joins two homologous C2 domains. The C2A domain binds to phospholipid membranes and other accessory proteins in a divalent cation-dependent fashion. The C2B domain promotes binding to other C2B domains, as well as accessory proteins independent of divalent cations. The 3.2 Å crystal structure of synaptotagmin III, residues 295–566, which includes the C2A and C2B domains, exhibits differences in the shape of the Ca⁺²-binding pocket, the electrostatic surface potential, and the stoichiometry of bound divalent cations for the two domains. These observations may explain the disparate binding properties of the two domains. The C2A and the C2B domains do not interact; synaptotagmin, therefore, covalently links two independent C2 domains, each with potentially different binding partners. A model of synaptotagmin's involvement in Ca⁺²-dependent regulation of membrane fusion through its interaction with the SNARE complex is presented.

Key Words: SNARE • synaptotagmin • C2 domains • crystallography • calcium-binding protein

© 1999 The Rockefeller University Press

EARLY characterization of synaptic exocytosis demonstrated that Ca⁺² floods into the synapse before the propagation of an action potential (Katz and Miledi 1967). This observation implied a receptor for this Ca⁺² signal on the presynaptic terminus. Calmodulin, protein kinase C (PKC)¹, and the annexins were suggested as possible candidates for the Ca⁺² trigger of exocytosis (Pollard et al. 1980; DeLorenzo 1982; Hutton 1986). More recently, however, strong evidence points to the synaptic vesicle protein, synaptotagmin, as the receiver for the Ca⁺² signal in the neuron. This protein could potentially transmit the Ca⁺² signal through its interactions with the SNARE (soluble N-ethylmaleimide–sensitive factor attachment protein receptor, SNAP receptor) complex at the presynaptic terminal (Brose et al. 1992; Bommert et al. 1993; Reist et al. 1998). Neurotransmitter filled vesicles could then fuse with the presynaptic membrane and release their contents into the synaptic cleft.

Synaptotagmin has been characterized in at least eight different isoforms in neurons. Several synaptotagmin isoforms also localize to nonneuronal cells (Li et al. 1995a). Therefore, this protein appears to be generally important in cellular exocytosis. Synaptotagmin is composed of a short intravesicular NH₂-terminal region, a single membrane spanning domain, a lysine- and arginine-rich region, and two homologous C2 domains. The C2 domain was first characterized in conventional protein kinase C isoforms (cPKC; Parker et al. 1986) and implicated in Ca⁺²-dependent phospholipid binding. The x-ray crystal structure of the C2A domain of synaptotagmin I (SytI) revealed a unique β-sandwich fold with a cluster of three Ca⁺²-binding loops at the apex of the fold (Sutton et al. 1995). In addition, the x-ray crystal structure of the isolated C2 domain from PKC-β (Sutton and Sprang 1998), the solution NMR structure of synaptotagmin I C2A (Shao et al. 1998), and the crystal structure of PLC-1 (Essen et al. 1997) identified up to three Ca⁺²-binding sites within the Ca⁺²-binding pockets of their respective C2 domains. Upon Ca⁺² binding, few structural changes occur in the divalent cation-binding pocket, apart from changes of the sidechain rotamers of the Ca⁺² coordinating aspartate residues (Sutton et al. 1995; Shao et al. 1998). The bound calcium ions quench the negative electrostatic potential within the divalent cation-binding pocket, and the more positive potential from peripheral basic residues dominate the interaction between synaptotagmin and target proteins (Shao et al. 1997). This "electrostatic switch" mechanism may also regulate the interaction of the C2A domain with phospholipid membranes (Davletov et al. 1998).

In vitro, synaptotagmin interacts with several proteins that are essential for exocytotic and endocytotic processes. In its role as a regulator of synaptic vesicle fusion, the C2B domain of synaptotagmin I binds the SNARE protein SNAP-25 (Schiavo et al. 1997) and the C2A domains bind syntaxin-1A (Bennett et al. 1992). The sites of interaction with syntaxin-1A map to a cluster of residues near the Ca⁺²-binding pocket of the C2A domain (Shao et al. 1997). Interestingly, this cluster site coincides with much of the phospholipid-binding region of the C2A domain of SytI (Chae et al. 1998). Synaptotagmin binds β-SNAP, but not -SNAP, with a high degree of selectivity (Schiavo et al. 1995); however, the physiological function of this interaction has yet to be established. Synaptotagmin also interacts with the N and P/Q-type Ca⁺² channels (Leveque et al. 1994; Martin-Moutot et al. 1996). This interaction implies that exocytosis may occur near the Ca⁺² channel where the Ca⁺² concentration in the neuron is highest upon depolarization. Synaptotagmin also interacts with the endocytotic adapter protein AP-2 (Zhang et al. 1994). Most recently, synaptotagmin has been implicated as a receptor for clostridial neurotoxins (Nishiki et al. 1994; Li and Singh 1998).

Although most biochemical studies of synaptotagmin have been carried out with the isolated C2A domain of synaptotagmin I, a few studies suggest that the C2B domain may be responsible for homo- and hetero-oligomerization of synaptotagmin isoforms (Chapman et al., 1996). Synaptotagmin I and synaptotagmin II, III can form homo- and heterodimers in a Ca⁺²-dependent manner (Chapman et al. 1998; Osborne et al. 1999). Likewise, synaptotagmin I and synaptotagmin IV also form heterodimers (Littleton et al. 1999). Therefore, synaptotagmin's ability to associate in various combinations with other isoforms may regulate synaptic diversity. Synaptotagmin can also associate and distinguish between various forms of inositol-polyphosphates through the polybasic region of the C2B domains (Schiavo et al. 1996; Mehrotra et al. 1997). These compounds are known to directly interfere with exocytosis and may be involved in the synaptic vesicle fusion process.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Cloning and Expression
The cDNA corresponding to the mouse gene of synaptotagmin III C2A-C2B, residues 295–569 (33,000 kD), was subcloned into pET28A using the NdeI-HinDIII cloning site. The expression plasmid was transformed into BL21(DE3). The bacteria were grown in a BIOFLO3000 using ECPYM1 media (Bernard and Payton 1995) with 50 mg/ml kanamycin sulfate. Heterologous protein expression was initiated at OD₆₀₀ 50.0 with 300 mM IPTG for 3 h at 37°C. Cells were harvested and frozen in liquid nitrogen until needed.

Gel Shift Assay
Native gel electrophoresis was carried out using 10–15% native Phast (Pharmacia) gels with native buffer strips soaked for 2 h in 0.88 M L-alanine, 0.25 M Tris, pH 8.8, and 1 mM EDTA before running the gel. Samples were mixed and allowed to incubate for at least 1 h in 20 mM Hepes, pH 7.8, 150 mM NaCl, 5 mM DTT, and 1 mM EDTA before loading the gel. The concentration of both proteins was determined by amino acid analysis (Keck facility, Yale University). SNARE core complex was expressed in a polycistronic T7 expression vector containing rat synaptobrevin-II, residues 1–96, rat syntaxin-1A, residues 180–262, rat SNAP-25A residues 1–83 and residues 130–206, and purified according to previously published methods (Sutton et al. 1998).

Purification and Crystallization
30 g of frozen bacterial cells were resuspended in 125 ml of extraction buffer (100 mM sodium phosphate, pH 8.0, 200 mM NaCl, and 10% ethylene glycol) with 200 mg of lysozyme and 0.5% Triton X-100. Passing the lysate twice through a pneumatic cell cracker (Microfluidics) at 10,000 lb/in² facilitated cell lysis. The histidine-tagged protein was incubated in batch with NTA-Ni (Qiagen) resin overnight at 4°C while slowly mixing. The resin was washed in a column with extraction buffer including 50 mM imidazole until the OD₂₈₀ was below 0.05. The tagged protein was eluted with 300 mM imidazole. At this point, 10% ethylene glycol, and 5 mM CaCl₂ were added to the protein solution. Under these conditions, synaptotagmin III precipitated and was removed by centrifugation in a GSA rotor at 10,000 rpm for 20 min. The protein pellet was washed in 25 mM ethanolamine, pH 8.5, 300 mM NaCl, and 10% ethylene glycol. The protein was resuspended in 30 ml of 50 mM sodium phosphate, pH 7.8, and 5 mM EDTA. The histidine tag was removed by cleaving the protein with TEV protease (BRL) overnight at 4°C. The resuspended protein was filtered through a 0.22-µm filter before ion exchange chromatography with a Mono Q 5/5 (Pharmacia) column in 25 mM ethanolamine, pH 8.0. The purified protein eluted from a 0–1-M NaCl gradient at 200 mM NaCl. The protein was concentrated to 40 mg/ml. Synaptotagmin III C2A-C2B crystallized in 1.5 M MgCl₂ and 100 mM MES, pH 6.5, at 20°C using the hanging drop method. Large hexagonal crystals grew after 1 wk.

Data Collection
Analysis of the systematic absences in the diffraction data narrowed possible space groups choices to either P6₁22 or P6₂22: a = 126 Å, b = 126 Å, c = 118 Å. Inspection of the molecular replacement solution of the C2A domain uniquely determined P6₂22. The Matthews coefficient calculation predicted two molecules in the asymmetric unit given average solvent content; however, only one protein molecule was found resulting in a solvent content of 70%. Native and trimethyl lead acetate (TMLA) data were collected at station BL1-5 at SSRL at a temperature of 20°C. Diffraction data from several crystals were merged to obtain highly redundant and complete native and anomalous derivative data sets. Diffraction data of the derivative were collected at a wavelength of 1.00 Å to take advantage of the lead (Pb) anomalous signal. Diffraction data were integrated and scaled using the DENZO package (Otwinowski and Minor 1998; Table ).

Refinement
The model phases were used as prior phase probability distributions to feed back into the heavy atom model refinement resulting in significantly improved SIRAS phases. The MLHL target function (Pannu et al. 1998) was used with the SIRAS experimental phases. Refinement included several rounds of conjugate gradient minimization, torsion angle simulated annealing at 3,000 K (Rice and Brunger 1994), grouped B-factor refinement for both domains, and individual B-factor refinement for the C2A domain only (Table , A and B). Refinement progress was monitored by a concomitant drop in R_free (Brunger 1992) and R. All phasing and refinement calculations were carried out with CNS (Brunger et al. 1998). The bulk solvent model used a density level (_sol) of 0.27 e^–/ų and a B-factor of 25 Ų. The final model had 98.7% of all residues in allowed regions. Three residues in the C2B domain are reported as disallowed (Ala 553, Lys 557, and Ser 475). Due to the disorder in a portion of the C2B domain, several side chain rotamers could not be absolutely determined and were set to those found in common with the PKC-β (1a25) and the synaptotagmin I (1rsy) C2 domains. It should be noted, however, that the side chain rotamers in the Ca⁺²-binding region of the C2B domain could be unambiguously assigned (see Fig. 3 A). The Mg⁺² and the sulfate ions were included in the model after the protein tracing was completed. It should be noted that at this resolution one cannot exclude the possibility that some of the Mg⁺² electron density peaks correspond to ordered water molecules. However, the observed Mg⁺² sites correspond to known sites in the divalent cation-binding sites of other C2 domains. The last few COOH-terminal residues of synaptotagmin III are predicted to be -helical by secondary structure prediction (King and Sternberg 1996). Although they are present in the expression construct used for crystallization, they were disordered in the crystal structure.

View larger version (118K): [in this window] [in a new window] [Download PPT slide]   Figure 3 (A) Experimental electron density map using native amplitudes and density modified SIRAS phases of the C2A and C2B Ca+2-binding pockets contoured at 1.5 . Some of the coordinating aspartic acid residues are shown as balls-and-sticks. The labels for the Mg+2 sites follow the numbering convention of the C2 domain of PLC-1 (Essen et al. 1997). (B) Connelly surface obtained by MidasPlus of synaptotagmin III C2A and C2B using a probe radius of 1.4 Å. Arrows point to the divalent binding pockets in the C2 domains.

	Results

Top Abstract Materials and Methods Results Discussion References

View larger version (27K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Overall structure of the cytosolic domain of synaptotagmin III. The gold arrows correspond to β-strands, the blue corresponds to -helices, and the red spheres to Mg+2.

The relative orientation of the two C2 domains (Fig. 1) represents the conformation of synaptotagmin III C2A-C2B favored by crystallization. The observed partial disorder of the C2B domain in this crystal form suggests that the relative orientation and position of the two C2 domains is variable in solution. This anisotropic disorder is confined to the plane of the β-sandwich, and the electron density of the β-sheets of the C2B domain is somewhat smeared out. However, the electron density for the C2B domain at the apex of the fold, including the Ca⁺²-binding pocket, is well defined, allowing sidechain interpretation of the Ca⁺²-binding region of the C2B domain (see Fig. 3 A).

The C2A and C2B domains are structurally similar with the exception of the -helix between the strands β7 and β8 of each C2 domain (Fig. 1 and Fig. 2). The seven-residue -helix of the C2B domain is not present in either the C2A domain of synaptotagmin I, the isolated C2 domain of PKC-β, or the type-II (P-type) C2 domain of PLC-1. This conserved -helical insertion has also been reported in the isolated C2B domain of rabphilin-3A (Ubach et al. 1999) and may have functional importance (Chung et al. 1998). The root-mean-square difference (Rmsd) between the rabphilin C2B and the synaptotagmin III C2B domains computed over all C atoms is 1.5Å.

View larger version (33K): [in this window] [in a new window] [Download PPT slide]   Figure 2 Sequence alignment of the synaptotagmin homology group with ClustalW: yellow arrows correspond to β-strands in the C2A domain; gold arrows correspond to β-strands in the C2B domain; green waves correspond to the flexible linker. Blue helices correspond to -helices. Syt3, mouse synaptotagmin III (294–588) (Swiss-Prot: SYT3_MOUSE); Syt1, mouse synaptotagmin I (271–421) (Swiss-Prot: SYT1_MOUSE); Syt4, rat synaptotagmin IV (152–425) (Swiss-Prot: SYT4_RAT); Syt5, rat synaptotagmin V (105–386) (Swiss-Prot: SYT3_RAT); Syt6, rat synaptotagmin VI (226–511) (GenBank: U2O105); Syt7, rat synaptotagmin VII (129–403) (GenBank: U20106); Syt8, mouse synaptotagmin VIII (61–355); Syt11, rat synaptotagmin XI (152–430) (GenBank:AF000432); rab3A, rat rabphilin-3a (383–684) (SWISS-PROT: RP3A_RAT); doc2, mouse doc2 (125–412) (PIR: JC4921).

Ca⁺²-Binding Pockets
Synaptotagmin III crystallized in the presence of 1.5 M MgSO₄. Although Mg⁺² could potentially mimic Ca⁺² binding, the aspartate residues in the C2A domain that have been shown by solution NMR and x-ray crystallography to pivot upon divalent cation binding, are not in the Ca⁺²-bound conformation (Fig. 3 A). Under these crystallization conditions, the synaptotagmin III C2A domain is in the unliganded conformation. However, three peaks in electron density difference maps were found in the Ca⁺²-binding pocket of the C2A domain. These peaks coincide with the positions of the three calcium ions in the PKC-β C2 structure and were interpreted as Mg⁺². The Mg⁺² could be responding to the negative electrostatic field from the aspartate residues within the divalent cation-binding pocket of the C2A domain without proper coordination of the aspartate residues.

In the C2B domain, significant electron density, consisting of a single 5 peak, was also found in the vicinity of the Ca⁺²-binding region (Fig. 3 A). This peak corresponds to the high affinity Ca⁺² site observed in the crystal structures of the synaptotagmin I C2A, the PKC-β C2, and the PLC-1 C2 domains. Although the divalent cation coordinating aspartate residues are present in the C2B domain, only one Mg⁺² binds in the divalent cation-binding pocket, despite the very high Mg⁺² concentration used for crystallization. The interpretation of this electron density peak in terms of a divalent cation-binding site is supported by the observed substitution of the site by a trimethyl lead ion in the TMLA derivative.

The Inter-Domain Linker
The linker between C2 domains for most of the synaptotagmin isoforms, including synaptotagmin III, is seven to nine residues in length (Fig. 2). The amino acid composition of synaptotagmin III suggests a rather flexible linkage with two contiguous glycine residues. The primary sequence of the linker is not conserved among the synaptotagmin homology group (Fig. 2). The inter-domain linker may be more rigid for the synaptotagmin isoforms that have fewer glycine residues and more proline residues, such as synaptotagmin VII or synaptotagmin VIII (Fig. 2). The rigidity of the inter-domain linker in some synaptotagmin isoforms may position the C2 domains for docking to vesicle-fusion related protein complexes, or otherwise restrict the range of motion possible between the two C2 domains. Other tandem C2 domain containing proteins such as rabphilin (Shirataki et al. 1993) or rim (Wang et al. 1997) have much longer linkers, thus providing more flexibility between C2 domains.

	Discussion

Top Abstract Materials and Methods Results Discussion References

 
Structural Implications for Biochemically Distinct C2 Domains
Synaptotagmin III is characterized by promiscuous binding to various accessory proteins and membrane components (Li et al., 1995). The two C2 domains of synaptotagmin have different binding partners and binding affinities. The x-ray crystal structure of the cytosolic domain of synaptotagmin III provides a structural explanation of these disparities between the two C2 domains. Despite the lack of Ca⁺² in the crystallization condition, this structure could still mimic some of the Ca⁺²-binding properties of C2B domains in the synaptotagmin homology group. In the crystal structure, the C2B domain associates with only one Mg⁺². The reduced divalent cation-binding capacity of the C2B domain would leave this area of the molecule with a residual negative charge relative to the C2A domain. This difference between the C2A and C2B domains may explain some of the biochemical differences observed in in vitro experiments. Overall, the C2A domain of synaptotagmin III has a more uniform electrostatic surface potential than the C2B domain (Fig. 4). The surface of the C2B domain possesses distinctly basic and acidic areas (Fig. 4). These charged areas may be important for the Ca⁺²-independent interactions observed in the isolated C2B domain.

View larger version (55K): [in this window] [in a new window] [Download PPT slide]   Figure 4 Surface plot showing the electrostatic potential of synaptotagmin. Blue, positive; red, negative charge. Charges were obtained from the OPLS force field. The electrostatic surface was contoured between –10kT/e and +10kT/e. Figure prepared with GRASP (Nicholls et al. 1991).

A sulfate ion from the crystallization medium is located near Lys 356 of the C2A domain of synaptotagmin III. This ion may mimic phospholipid binding to synaptotagmin, since this face of the C2A domain interacts with the phospholipid bilayer (Chae et al. 1998). The crystal structure of the C2A domain of synaptotagmin I also contained a sulfate ion derived from the crystallization (Sutton et al. 1995). The sulfate ion in this structure is in a different position; however, it is associated with the same face of the protein. This indicates that the electrostatic potential is positively charged at this location on the protein.

Model of C2B-mediated Oligomerization
Only one molecule is present in the asymmetric unit of this crystal form. The crystallographic symmetry together with primary sequence analysis of the available synaptotagmin isoforms may provide clues to the mechanism of C2B domain homo- and heterodimerization. Two crystallographically related molecules in this hexagonal crystal form direct their divalent cation-binding pockets toward the sixfold crystallographic axis. The resulting crystal packing contacts include the sequence Asp-Phe-Asp (386–388), which includes two of the divalent cation-binding residues in C2 domains. These three residues are conserved in all C2A domains with the exception of synaptotagmin VII. In the C2B domain, the homologous motif is Asp-Tyr-Asp (520–522), with few exceptions among the other synaptotagmin isoforms. In the crystal structure of the synaptotagmin III C2A-C2B domains, an alternate rotamer of Tyr 521 can be modeled to coordinate Asp 466 of the crystallographically related molecule to form a hydrogen bond. Aspartate 466 anchors the divalent cation-binding chain in the Ca⁺²-binding pocket of C2 domains. This putative interaction may provide an initial nucleation point for self-association. The sequence variability present in the other isoforms of synaptotagmin, for example, synaptotagmin VII, VIII, and XI, may modulate their individual binding properties to other synaptotagmin isoforms.

Interactions of Synaptotagmin with the SNARE Complex
The core of the SNARE complex, composed of synaptobrevin-II (1–96), syntaxin-1A (180–262), SNAP-25A (1–83), and SNAP-25A (130–206), interacts with the C2A and C2B domains of synaptotagmin III independent of divalent cations (Fig. 5). We have modeled the association between these two moieties using the following arguments: first, the position of the presynaptic membrane restricts the possible contacts between the two C2 domains of synaptotagmin and the SNARE complex. The syntaxin component of the SNARE complex embeds its transmembrane -helix into the presynaptic membrane; likewise, the synaptobrevin transmembrane -helix is anchored in the vesicle phospholipid membrane. Our model, therefore, puts the synaptobrevin -helix on top of the complex and the syntaxin -helix on the bottom relative to the presynaptic membrane bilayer on the bottom of Fig. 6. The palmitoylated SNAP-25 linker would also contact the presynaptic membrane, so it localizes to the membrane associated with syntaxin. Second, the divalent cation-binding loops (CalB) of the C2 domains of PLA2 contact phospholipid bilayer with some residues embedded in the bilayer itself (Chae et al. 1998; Ball et al. 1999). Ca⁺² in the CalB region either directly binds phospholipid headgroups through Ca⁺² bridging (Swairjo et al. 1995) or indirectly binds by quenching the electrostatic charge of the CalB domain, in situ (Shao et al. 1997). This restriction would allow the C2A and C2B domains of synaptotagmin to straddle the fusion complex and to interact simultaneously with the presynaptic membrane. Third, the unique electrostatic properties of the SNARE complex and synaptotagmin allow the positively charged, polybasic region of the C2 domains to interact with the negatively charged surface at the center of the SNARE complex (Sutton et al. 1998). Fourth, the cupped shape of the polybasic region of the C2 domains provides a favorable interaction surface with the cylindrical SNARE complex. Fifth, the length and flexibility of the inter-domain linker restrict the possible C2 domain orientation with respect to the SNARE complex. Most isoforms of synaptotagmin have inter-domain linkers of eight to nine residues in length (Fig. 2). The C2 domains presumably act as independent rigid bodies, so the inter-domain linker governs the available flexibility between them. The amino acid composition of this linker is not conserved among synaptotagmin isoforms. The proportion of glycine residues and therefore, the degree of flexibility possible between C2 domains varies by isoform. Some of the linker regions of synaptotagmin contain proline residues; therefore, the C2 domains of these isoforms are probably more restricted in their possible orientations.

View larger version (36K): [in this window] [in a new window] [Download PPT slide]   Figure 5 Ca+2-independent synaptotagmin-SNARE complex interaction: 10–15% native Phast gel (Pharmacia) run in the presence of 1 mM EDTA. Lanes B–F contain 1.6 µg of core SNARE complex; lanes A–E contain 3.2, 3.2, 2.4, 1.6, and 0.8 µg of synaptotagmin III C2AB.

View larger version (48K): [in this window] [in a new window] [Download PPT slide]   Figure 6 Cartoon illustrating the proposed association between synaptotagmin (gold colored protein) and the SNARE fusion complex (SNAP25, green helix; syntaxin, red helices; and synaptobrevin, blue helix) and the interaction with the phospholipid membrane (yellow plane). Ca+2 are illustrated as red spheres. The transmembrane anchor of syntaxin and the linker between the H1-H2 domain (red helices to the left of C2A) and the H3 domain of syntaxin (red helices in the SNARE bundle) have been omitted for clarity. In our model, we predict that the Ca+2-binding sites of synaptotagmin interact with the presynaptic membrane. The interactions between the SNARE complex and synaptotagmin probably involve the COOH-terminal (membrane-proximal) portion of the SNARE core complex (Kee and Scheller 1996) and the cup-shaped, polybasic regions of the synaptotagmin C2 domains. The association between the NH2-terminal (H1-H2) domain of syntaxin (red helices to the left of the C2A domain) and the C2A domain of synaptotagmin was modeled according to NMR data (Shao et al. 1997). The peptide distance between the transmembrane domain and the SNARE-binding domain of synaptobrevin (blue helix) is exaggerated in this cartoon.

According to the zipper model of SNARE-mediated fusion (Hanson et al. 1997; Lin and Scheller 1997; Fiebig et al. 1999), the SNARE proteins associate from the NH₂ to COOH terminus as the neurotransmitter-filled synaptic vesicle and presynaptic membranes approach each other. In the early stages of fusion, synaptotagmin may act as a negative regulator of exocytosis by preventing the completion of the "zippering" action of the SNARE complex by binding to the COOH-terminal, membrane attachment side of the SNARE complex through surface electrostatic interactions on the fusion complex, independent of divalent cations. Indeed, synaptotagmin may bind with higher affinity to the partially assembled SNARE complex than to the fully assembled complex. When an action potential or other fusion signal triggers a Ca⁺² flux, as in the case of neuronal exocytosis, synaptotagmin may then bind to the presynaptic phospholipid membrane in a Ca⁺²-dependent manner in preference to the SNARE complex. Therefore, synaptotagmin binding to the SNARE complex or the presynaptic membrane would be mutually exclusive properties of synaptotagmin. Once synaptotagmin is associated with the membrane, the SNARE complex would then be available to mediate fusion between the vesicle membrane and the presynaptic phospholipid membrane.

	Acknowledgments

 
The authors thank P.D. Adams for stimulating discussions and H. Bellamy for assistance with data collection at SSRL BL1-5. We would like to thank Pat Fleming for help with the packing analysis of synaptotagmin III, Thomas Südhof for the initial clone synaptotagmin III, Josep Rizo for the help with the correct alignment of C2B domains, Mark Bowen for helpful discussion, Mike Reese and Steve Kaiser for preparing the fusion complex, and Stephen Sprang who provided a Welsh grant (I-1229) for early work on synaptotagmin III.

The SSRL Biotechnology Program is supported by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program and the Department of Energy, Office of Biological and Environmental Research. J.A. Ernst is supported by a pre-doctoral fellowship in biophysics from the National Science Foundation. Coordinates will be deposited with the PDB and are also at http://atb.csb. yale.edu.

Submitted: 2 August 1999

Revised: 22 September 1999

Accepted: 30 September 1999

1.used in this paper: PKC, protein kinase C; SNARE, soluble N-ethylmaleimide–sensitive factor attachment protein receptor; SIRAS, single isomorphous replacement, anomalous scattering; SytI, synaptotagmin I; TMLA, trimethyl lead acetate

	References

Top Abstract Materials and Methods Results Discussion References

 

Ball A., Nielsen R., Gelb M.H. & Robinson B.H.. Interfacial membrane docking of cytosolic phospholipase A2 C2 domain using electrostatic potential-modulated spin relaxation magnetic resonance, Proc. Natl. Acad. Sci. USA., 96, 1999, 6637–6642.[Abstract/Free Full Text]

Bennett M.K., Calakos N. & Scheller R.H.. Syntaxina synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones, Science., 257, 1992, 255–259.[Abstract/Free Full Text]

Bernard A. & Payton M.. Fermentation and growth of Escherichia coli for optimal protein production, Curr. Prot. Prot. Sci., 5, 1995, 1–18.

Bommert K., Charlton M.P., DeBello W.M., Chin G.J., Betz H. & Augustine G.J.. Inhibition of neurotransmitter release by C2-domain peptides implicates synaptotagmin in exocytosis, Nature., 363, 1993, 163, .[Medline]

Brose N., Petrenko A.G., Südhof T.C. & Jahn R.. Synaptotagmina calcium sensor on the synaptic vesicle surface, Science., 256, 1992, 1021–1025.[Abstract/Free Full Text]

Brunger A.T.. The free R valuea novel statistical quantity for assessing the accuracy of crystal structures, Nature., 355, 1992, 472–474.[Medline]

Brunger A.T., Adams P.D., Clore G.M., Gros P., Grosse-Kunstleve R.W., Jiang J.-S., Kuszewski J., Nilges M., Pannu N.S. & Read R.J.. Crystallography & NMR System (CNS)a new software system for macromolecular structure determination, Acta Cryst. D., 54, 1998, 905–921.[Medline]

Chae Y.K., Abildgaard F., Chapman E.R. & Markley J.L.. Lipid binding ridge on loops 2 and 3 of the C2A domain of synaptotagmin I as revealed by NMR spectroscopy, J. Biol. Chem., 273, 1998, 25659–25663.[Abstract/Free Full Text]

Chapman E.R., Desai R.C., Davis A.F. & Tornehl C.K.. Delineation of the oligomerization, AP-2 binding, and synprint binding region of the C2B domain of synaptotagmin, J. Biol. Chem., 273, 1998, 32966–32972.[Abstract/Free Full Text]

Chapman E.R., Hanson P.I., An S. & Jahn R.. Ca⁺² regulates the interaction between synaptotagmin and syntaxin 1, J. Biol. Chem, 270, 1995, 23667–23671.[Abstract/Free Full Text]

Chung S.-H., Song W.-J., Kim K., Bednarski J., Chen J., Prestwich G.D. & Holz R.W.. The C2 domains of rabphilin 3A specifically bind phosphatidylinositol 4,5-biphosphate containing vesicles in a Ca⁺²-dependent manner, J. Biol. Chem., 273, 1998, 10240–10248.[Abstract/Free Full Text]

Davletov B., Perisic O. & Williams R.L.. Calcium-dependent membrane penetration is a hallmark of the C2 domain of cytosolic phospholipase A2 whereas the C2A domain of synaptotagmin binds membranes electrostatically, J. Biol. Chem., 273, 1998, 19093–19096.[Abstract/Free Full Text]

DeLorenzo R.J.. Calmodulin in neurotransmitter release and synaptic function, Fed. Proc., 41, 1982, 2265–2272.[Medline]

Essen L.O., Perisic O., Lynch D.E., Katan M. & Williams R.L.. A ternary metal binding site in the C2 domain of phosphoinositide-specific phospholipase C-1, Biochemistry., 36, 1997, 2753–2762.[Medline]

Fiebig K.M., Rice L.M., Pollock E. & Brunger A.T.. Folding intermediates of SNARE complex assembly, Nat. Struct. Biol., 6, 1999, 117–123.[Medline]

Fukuda M., Kojima T. & Mikoshiba K.. Regulation by bivalent cations of phospholipid binding to the C2A domain of synaptotagmin III, Biochem. J., 323, 1997, 421–425.[Medline]

Grosse-Kunstleve R.W. & Brunger A.T.. A highly automated heavy-atom search procedure for macromolecular structures, Acta Cryst. D., In press, 1999.

Hanson P.I., Roth R., Morisaki H., Jahn R. & Heuser J.E.. Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy, Cell., 90, 1997, 523–535.[Medline]

Hutton J.C.. Calcium-binding proteins and secretion, Cell Calcium., 7, 1986, 339–352.[Medline]

Jones T.A. J.Y., Zou S., Cowan & Kjeldgaard M.. Improved methods for building protein models in electron density maps and the location of errors in these models, Acta Cryst. A., 47, 1991, 110–119.[Medline]

Katz B. & Miledi R.. On the timing of calcium action during neuro-muscular transmission, J. Physiol., 187, 1967, 535–544.

Kee Y. & Scheller R.H.. Localization of synaptotagmin-binding domains on syntaxin, J. Neurosci., 16, 1996, 1975–1981.[Abstract/Free Full Text]

King R.D. & Sternberg M.J.. Identification and application of the concepts important for accurate and reliable protein secondary structure prediction, Prot. Sci., 5, 1996, 2298–2310.[Medline]

Leveque C., el Far O., Martin-Moutot N., Sato K., Kato R., Takahashi M. & Seagar M.J.. Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicle exocytosis, J. Biol. Chem., 269, 1994, 6306–6312.[Abstract/Free Full Text]

Li C., Ullrich B., Zhang J., Anderson R., Brose N. & Südhof T.. Ca⁺²-dependent and –independent activities of neural and non-neural synaptotagmins, Nature., 375, 1995, 594–599a.[Medline]

Li C., Davletov B.A. & Südhof T.C.. Distinct Ca⁺² and Sr⁺² binding properties of synaptotagmins. Definition of candidate Ca⁺² sensors for the fast and slow components of neurotransmitter release, J. Biol. Chem., 270, 1995, 24898–24902b.[Abstract/Free Full Text]

Li L. & Singh B.R.. Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay, J. Nat. Toxins, 7, 1998, 215–226.[Medline]

Lin R.C. & Scheller R.H.. Structural organization of the synaptic exocytosis core complex, Neuron., 19, 1997, 1087–1094.[Medline]

Littleton J.T., Serano T.L., Rubin G.M., Ganetzky B. & Chapman E.R.. Synaptic function modulated by changes in the ratio of synaptotagmin I and IV, Nature., 400, 1999, 757–760.[Medline]

Martin-Moutot N., Charvin N., Leveque C., Sato K., Nishiki T., Kozaki S., Takahashi M. & Seagar M.. Interaction of SNARE complexes with P/Q-type calcium channels in rat cerebellar synaptosomes, J. Biol. Chem., 271, 1996, 6567–6570.[Abstract/Free Full Text]

Mehrotra B., Elliott J.T., Chen J., Olszwqkei J., Profit A., Chaudhary A., Fukuda M., Mikshiba K. & Prestwich G.. Selective photoaffinity labeling of the inositol polyphosphate binding C2B domains of synaptotagmins, J. Biol. Chem., 272, 1997, 4237–4244.[Abstract/Free Full Text]

Nicholls A., Sharp K.A. & Honig B.. Protein folding and associationInsights from the interfacial and thermodynamic properties of hydrocarbons, Proteins Struct. Funct. Genet., 11, 1991, 281–296.[Medline]

Nishiki T., Kamata Y., Nemoto Y., Omori A., Ito T., Takahashi M. & Kozaki S.. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes, J. Biol. Chem., 269, 1994, 10498–10503.[Abstract/Free Full Text]

Osborne S.L., Herreros J., Bastiaens P.I. & Schiavo G.. Calcium-dependent oligomerization of synaptotagmins I and II. Synaptotagmins I and II are localized on the same synaptic vesicle and heterodimerize in the presence of calcium, J. Biol. Chem., 274, 1999, 59–66.[Abstract/Free Full Text]

Otwinowski Z. & Minor W.. Processing of x-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 1998, 307–326.

Pannu N.S., Murshudov G.N., Dodson E.J. & Read R.J.. Incorporation of prior phase information strengthens maximum likelihood structural refinement, Acta Cryst. D., 54, 1998, 1285–1294.[Medline]

Parker P.J., Coussens L., Totty N., Rhee L., Young S., Chen E., Stabel S., Waterfield M.D. & Ullrich A.. The complete primary structure of protein kinase C—the major phorbol ester receptor, Science., 233, 1986, 853–859.[Abstract/Free Full Text]

Pollard H.D., Pazoles C.J., Creutz C. & Zinder O.. Role of intracellular proteins in the regulation of calcium action and transmitter release during exocytosis, Monogr. Neural Sci., 7, 1980, 106–116.[Medline]

Reist N.E., Buchanan J., Li J., DiAntonio A., Buxton E.M. & Schwarz T.L.. Morphologically docked synaptic vesicles are reduced in synaptotagmin mutants of Drosophila, J. Neurosci., 18, 1998, 7662–7673.[Abstract/Free Full Text]

Rice L.M. & Brunger A.T.. Torsion angle dynamicsreduced variable conformational sampling enhances crystallographic structure refinement, Proteins Struct. Funct. Genet., 19, 1994, 277–290.[Medline]

Schiavo G., Gmachl M.J., Stenbeck G., Sollner T.H. & Rothman J.E.. A possible docking and fusion particle for synaptic transmission, Nature., 378, 1995, 733–736.[Medline]

Schiavo G., Gu Q.M., Prestwich G.D., Sollner T.H. & Rothman J.E.. Calcium-dependent switching of the specificity of phosphoinositide binding to synaptotagmin, Proc. Natl. Acad. Sci. USA., 93, 1996, 13327–13332.[Abstract/Free Full Text]

Schiavo, G., G. Stenbeck, J.E. Rothman, and T.H. Sollner. 1997. Binding of the synaptic vesicle v-SNARE, synaptotagmin, to the plasma membrane t-SNARE, SNAP-25, can explain docked vesicles at neurotoxin-treated synapses. Proc. Natl. Acad. Sci. USA. 997–1001.

Shao X., Li C., Fernandez I., Zhang X., Südhof T.C. & Rizo J.. Synaptotagmin-syntaxin interactionthe C2 domain as a Ca⁺²-dependent electrostatic switch, Neuron., 18, 1997, 133–142.[Medline]

Shao X., Fernandez I., Südhof T.C. & Rizo J.. Solution structures of the Ca⁺²-free and Ca⁺²-bound C2A domain of synaptotagmin Idoes Ca⁺²induce a conformational change?, Biochemistry., 37, 1998, 16106–16115.[Medline]

Shirataki H., Kaibuchi K., Sakoda T., Kishida S., Yamaguchi T., Wada K., Miyazaki M. & Takai Y.. Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin, Mol. Cell Biol., 13, 1993, 2061–2068.[Abstract/Free Full Text]

Sutton R.B., Davletov B.A., Berghuis A.M., Südhof T.C. & Sprang S.R.. Structure of the first C2 domain of synaptotagmin Ia novel Ca⁺²/phospholipid-binding fold, Cell., 80, 1995, 929–938.[Medline]

Sutton R.B., Fasshauer D., Jahn R. & Brunger A.T.. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution, Nature., 395, 1998, 347–353.[Medline]

Sutton R.B. & Sprang S.R.. Structure of the protein kinase C-β phospholipid-binding C2 domain complexed with Ca⁺², Structure., 6, 1998, 1395–1405.[Medline]

Swairjo M.A., Concha N.O., Kaetzel M.A., Dedman J.R. & Seaton B.A.. Ca⁺²-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V, Nat. Struct. Biol., 2, 1995, 968–974.[Medline]

Ubach J., Garcia J., Nittler M.P., Südhof T.C. & Rizo J.. The C2B-domain of rabphilinstructural variations in a Janus-faced domain, Nat. Cell Biol., 1, 1999, 106–112.[Medline]

Wang Y., Okamoto M., Schmitz F., Hofmann K. & Südhof T.C.. Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion, Nature., 388, 1997, 593–598.[Medline]

Zhang J.Z., Davletov B.A., Südhof T.C. & Anderson R.G.. Synaptotagmin I is a high affinity receptor for clathrin AP-2implications for membrane recycling, Cell., 78, 1994, 751–760.[Medline]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This Article Abstract Full Text (PDF, 682K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Sutton, R. B. Articles by Brunger, A. T. Search for Related Content PubMed PubMed Citation Articles by Sutton, R. B. Articles by Brunger, A. T. Social Bookmarking                            What's this?